• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture

tetano

Editor, Senior Moderator
J Gen Virol. 2016 Jan 7. doi: 10.1099/jgv.0.000390. [Epub ahead of print]
[h=1]The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.[/h] Mostafa A[SUP]1[/SUP], Kanrai P[SUP]2[/SUP], Ziebuhr J[SUP]3[/SUP], Pleschka S[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza vaccine strains (IVS) contain the hemagglutinin (HA) and neuraminidase (NA) genome segments of relevant circulating strains in the genetic background of influenza A/PR/8/1934 virus (PR8). Previous work has shown that the nature of the PB1 segment may be a limiting factor for the efficient production of IVS. Here, we show that the PB1 segment (PB1Gi) from the 2009 pandemic influenza A virus (IAV) A/Giessen/06/2009 (Gi wt, H1N1pdm) may help to resolve (some of) these limitations. We produced a set of recombinant PR8-derived viruses that contained (i) the HA and NA segments from representative IAV strains (H3N2, H5N1, H7N9, H9N2), (ii) the PB1 segment from PR8 or Gi wt, respectively, and (iii) the remaining five genome segments from PR8. Viruses containing the PB1Gi segment, together with the heterologous HA/NA segments and five PR8 segments (5+2+1), replicated to higher titers compared to their 6+2 counterparts containing six PR8 segments and the equivalent heterologous HA/NA segments. Compared to PB1PR8-containing IVS, viruses with the PB1Gi segment replicated to higher or similar titers in both cell culture and embryonated eggs, most profoundly IVS of the H5N1 and H7N9 subtype, which are known to grow poorly in these systems. IVS containing either the PB1Gi or the cognate PB1 segment of the respective specific HA/NA donor strain showed enhanced or similar viral replication levels. The study suggests that substitution of PB1PR8 with the PB1Gi segment may greatly improve the large-scale production of PR8-derived IVS, especially of those known to replicate poorly in vitro.


PMID: 26743314 [PubMed - as supplied by publisher]
 
Back
Top Bottom